Patents
Patents for C07K 19 - Hybrid peptides (29,428)
04/2004
04/14/2004EP1408050A1 A method of producing glucagon-like peptide 1(glp-1)7-36 and an glp-1 analogue
04/14/2004EP1408049A2 A novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator
04/14/2004EP1407030A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
04/14/2004EP1407023A2 Group b streptococcus antigens and corresponding dna fragments
04/14/2004EP1407017A2 Human tumor necrosis factor receptor
04/14/2004EP1406929A2 Glycoprotein vi fusion proteins
04/14/2004EP1406925A2 Survivin interacting protein tpr1
04/14/2004EP1406923A2 Histidine phosphatase interacting protein with 180kd
04/14/2004EP1406657A1 A novel engineered superantigen for human therapy
04/14/2004EP1406644A2 Modified proteins, designer toxins, and methods of making thereof
04/14/2004EP1406573A2 Conditioned cell culture media and uses thereof
04/14/2004EP1036185B1 Proteinase inhibitor fusion proteins
04/14/2004CN1489692A HCV antigen/antibody combination assay
04/14/2004CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection
04/14/2004CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing
04/14/2004CN1488646A SARS virus S protein and N protein fusion protein, and preparation and use thereof
04/13/2004US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
04/13/2004US6719978 Virus-like particles for the induction of autoantibodies
04/13/2004US6719971 Method for making humanized antibodies
04/13/2004CA2195076C Process for modifying the stability of antibodies
04/08/2004WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis
04/08/2004WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/08/2004WO2003064468A3 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
04/08/2004WO2003042249A8 Peptide purification by means of metal ion affinity chromatography
04/08/2004US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
04/08/2004US20040067552 Adipocyte complement related protein zacrp14
04/08/2004US20040067520 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity
04/08/2004US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins
04/08/2004US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin
04/08/2004CA2816149A1 Optimized fc variants and methods for their generation
04/08/2004CA2499843A1 Novel compositions and methods for the treatment of psoriasis
04/07/2004EP1405911A1 Interaction trap systems for detecting protein interactions
04/07/2004EP1404865A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
04/07/2004EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same
04/07/2004EP1404716A2 Novel g protein-coupled receptors and dna sequences thereof
04/07/2004EP1404703A2 G-protein coupled receptors
04/07/2004EP1404362A2 Signal-1/signal-2 bifunctional peptide inhibitors
04/07/2004EP1145004B1 Methods for detecting changes to cellular components
04/07/2004CN1487085A Conotoxin MVÔàí A and Trx fusion protein and its expression and application
04/07/2004CN1144815C Modified i CE.(oli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein
04/06/2004US6716965 Adipocyte complement related protein zacrp13
04/06/2004US6716623 Compositions and methods for identifying antigens which elicit an immune response
04/06/2004US6716586 Insulin-like growth factor agonist molecules
04/06/2004CA2087286C Thioether conjugates
04/06/2004CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
04/01/2004WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis
04/01/2004WO2004026898A1 Peptide complexes containing phospholipase d
04/01/2004WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof
04/01/2004WO2004005473A3 Hcv fusion proteins with modified ns3 domains
04/01/2004WO2003097825A3 Novel phospholipases and uses thereof
04/01/2004WO2003087840A3 Protein involved in cancer
04/01/2004WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof
04/01/2004WO2003060090A3 Novel cytokine zcytor17 ligand
04/01/2004WO2003029282A3 Tumor-peptide antigens from the human prdi-bf1-protein
04/01/2004WO2002064631A3 T1r taste receptors and genes encoding same
04/01/2004WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
04/01/2004US20040063913 Antibodies to human il-1beta
04/01/2004US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
04/01/2004US20040063635 Recombinant human albumin fusion proteins with long-lasting biological effects
04/01/2004US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
04/01/2004US20040063092 Immunoassays for anti-HCV antibodies
04/01/2004CA2767235A1 Peptides and related molecules that modulate nerve growth factor activity
04/01/2004CA2474680A1 Method for analyzing organelle-localized protein and material for analysis
03/2004
03/31/2004EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
03/31/2004EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
03/31/2004EP1402040A2 A novel intein and uses thereof
03/31/2004EP1402035A2 G-protein coupled receptors and dna sequences thereof
03/31/2004EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein
03/31/2004EP1401999A2 B7 related protein-2 molecules and uses thereof
03/31/2004EP1401869A1 Molecules and methods for inhibiting shedding of kim-1
03/31/2004EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
03/31/2004EP1401467A1 Alpha-fetoprotein peptides and uses thereof
03/31/2004EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap)
03/31/2004EP1012256B1 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album
03/31/2004EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
03/31/2004CN1486368A Methods for the production of multimeric proteins, and related compositions
03/31/2004CN1486327A 载脂蛋白类似物 Apolipoprotein analogues
03/31/2004CN1486192A Binding domain-immunoglobulin fusion proteins
03/31/2004CN1143895C Gene engineering process for preparing diad/triad fusion protein of erythrocyte growth factor with improved bioactivity
03/30/2004US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents
03/30/2004US6713453 Sustained release; drug delivery; tissue adhesive
03/30/2004US6713451 Insulin-like growth factor agonist molecules
03/30/2004US6713450 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits
03/30/2004US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
03/30/2004US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor
03/30/2004US6713266 Immunoassay method for measuring a cyclosporine and its metabolites
03/30/2004CA2235471C Dna encoding a plasminogen activating protein
03/25/2004WO2004025264A2 Rapidly degraded reporter fusion proteins
03/25/2004WO2004024925A2 Collectin-complement activating protein chimeras
03/25/2004WO2004024909A2 Recombinant colstridium neurotoxin fragments
03/25/2004WO2004024189A1 Stable immunogenic product comprising antigenic heterocomplexes
03/25/2004WO2004024181A1 New tumor antigen vaccine and producing method and vaccine composition
03/25/2004WO2004024097A2 Compositions and methods for the treatment of immune related diseases
03/25/2004WO2004024077A2 Novel composition and methods for the treatment of psoriasis
03/25/2004WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases
03/25/2004WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor
03/25/2004WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor
03/25/2004WO2004018511A3 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
03/25/2004WO2003072804A3 Nanostructures containing pilin protein
03/25/2004WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof